InsiderClue
Insiders · Profile

GALA RENEE D

President & CEO at Jazz Pharmaceuticals · SVP, Chief Financial Officer at Theravance Biopharma · Director at CORCEPT THERAPEUTICS. Filing since 13 Aug 2015. CIK 0001607737

JAZZ Jazz Pharmaceuticals plc President & CEO · 4 trades TBPH Theravance Biopharma, Inc. SVP, Chief Financial Officer · 5 trades CORT CORCEPT THERAPEUTICS INC Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
JAZZ Jazz Pharmaceuticals plc
6 Oct 2026
President & CEO
Sold on a plan
2,000
$472.80K
1.4%
JAZZ Jazz Pharmaceuticals plc
8 Sep 2026
President & CEO
Sold on a plan
2,000
$486.06K
1.4%
JAZZ Jazz Pharmaceuticals plc
18 May 2023
EVP & Chief Financial Officer
Sold at will
6,000
$790.47K
14.3%
JAZZ Jazz Pharmaceuticals plc
21 Dec 2022
EVP & Chief Financial Officer
Sold, plan not stated
2,635
$421.60K
7.5%
TBPH Theravance Biopharma, Inc.
15 Aug 2018
SVP, Chief Financial Officer
Sold, plan not stated
41,539
$1.11M
19.5%
TBPH Theravance Biopharma, Inc.
14 Aug 2018
SVP, Chief Financial Officer
Sold, plan not stated
2,204
$61.14K
1.0%
TBPH Theravance Biopharma, Inc.
18 May 2018
SVP, Chief Financial Officer
Sold, plan not stated
10,000
$242.88K
4.1%
CORT CORCEPT THERAPEUTICS INC
7 Mar 2018
Director
Bought
9,000
$139.80K
900%
CORT CORCEPT THERAPEUTICS INC
6 Mar 2018
Director
Bought
1,000
$15.30K
opened
TBPH Theravance Biopharma, Inc.
17 Aug 2015
SVP, Chief Financial Officer
Bought
5,000
$60.80K
3.2%
TBPH Theravance Biopharma, Inc.
13 Aug 2015
SVP, Chief Financial Officer
Bought
5,000
$60.95K
3.3%
11 decisions on file.